Kaikkonen J - Search Results

1

Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium.

Salonen JT, Uimari P, Aalto JM, Pirskanen M, Kaikkonen J, Todorova B, Hyppönen J, Korhonen VP, Asikainen J, Devine C, Tuomainen TP, Luedemann J, Nauck M, Kerner W, Stephens RH, New JP, Ollier WE, Gibson JM, Payton A, Horan MA, Pendleton N, Mahoney W, Meyre D, Delplanque J, Froguel P, Luzzatto O, Yakir B, Darvasi A. Salonen JT, et al. Among authors: kaikkonen j. Am J Hum Genet. 2007 Aug;81(2):338-45. doi: 10.1086/520599. Epub 2007 Jun 26. Am J Hum Genet. 2007. PMID: 17668382 Free PMC article.

2

Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels.

Kaikkonen J, Tuomainen TP, Nyyssonen K, Salonen JT. Kaikkonen J, et al. Free Radic Res. 2002 Apr;36(4):389-97. doi: 10.1080/10715760290021234. Free Radic Res. 2002. PMID: 12069102 Clinical Trial.

3

New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.

Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, Seppälä E, Matikainen M, Kallioniemi OP, Schleutker J, Lehtimäki T, Salonen JT. Marchesani M, et al. Among authors: kaikkonen j. J Natl Cancer Inst. 2003 Jun 4;95(11):812-8. doi: 10.1093/jnci/95.11.812. J Natl Cancer Inst. 2003. PMID: 12783936

4

Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man.

Tuomainen TP, Diczfalusy U, Kaikkonen J, Nyyssönen K, Salonen JT. Tuomainen TP, et al. Among authors: kaikkonen j. Free Radic Biol Med. 2003 Oct 15;35(8):922-8. doi: 10.1016/s0891-5849(03)00433-7. Free Radic Biol Med. 2003. PMID: 14556856 Clinical Trial.

5

C18 hydroxy fatty acids as markers of lipid peroxidation ex vivo and in vivo.

Kaikkonen J, Tuomainen TP, Nyyssönen K, Morrow JD, Salonen JT. Kaikkonen J, et al. Scand J Clin Lab Invest. 2004;64(5):457-68. doi: 10.1080/00365510410006667. Scand J Clin Lab Invest. 2004. PMID: 15276910

6

Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma.

Nyyssönen K, Kaikkonen J, Salonen JT. Nyyssönen K, et al. Among authors: kaikkonen j. Scand J Clin Lab Invest. 1996 Dec;56(8):681-9. doi: 10.3109/00365519609088815. Scand J Clin Lab Invest. 1996. PMID: 9034349

7

Determinants of plasma coenzyme Q10 in humans.

Kaikkonen J, Nyyssönen K, Tuomainen TP, Ristonmaa U, Salonen JT. Kaikkonen J, et al. FEBS Lett. 1999 Jan 25;443(2):163-6. doi: 10.1016/s0014-5793(98)01712-8. FEBS Lett. 1999. PMID: 9989597 Free article. Clinical Trial.

8

Measurement and stability of plasma reduced, oxidized and total coenzyme Q10 in humans.

Kaikkonen J, Nyyssönen K, Salonen JT. Kaikkonen J, et al. Scand J Clin Lab Invest. 1999 Oct;59(6):457-66. doi: 10.1080/00365519950185481. Scand J Clin Lab Invest. 1999. PMID: 10612557

9

Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study.

Kaikkonen J, Nyyssönen K, Tomasi A, Iannone A, Tuomainen TP, Porkkala-Sarataho E, Salonen JT. Kaikkonen J, et al. Free Radic Res. 2000 Sep;33(3):329-40. doi: 10.1080/10715760000301501. Free Radic Res. 2000. PMID: 10993487 Clinical Trial.

10

Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men.

Nyyssönen K, Porkkala-Sarataho E, Kaikkonen J, Salonen JT. Nyyssönen K, et al. Among authors: kaikkonen j. Atherosclerosis. 1997 Apr;130(1-2):223-33. doi: 10.1016/s0021-9150(96)06064-9. Atherosclerosis. 1997. PMID: 9126668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page